Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
46,151
datasets available to search
ShareScore release 0.9.0
Dataset results
46,151 results for “Safety”
PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
ClinicalTrials.gov study NCT01212770. IPD Sharing: YES. Countries: 16. Publications: 6.
Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects
ClinicalTrials.gov study NCT01439373. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)
ClinicalTrials.gov study NCT04929483. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Long-Term Follow-up of Children for a 2-Year Period to Confirm the Safety and Immunogenicity of GSK 257049 Vaccine
ClinicalTrials.gov study NCT00323622. IPD Sharing: YES. Countries: 1. Publications: 3.
Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma
ClinicalTrials.gov study NCT02054130. IPD Sharing: Not stated. Countries: 12. Publications: 9.
Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure
ClinicalTrials.gov study NCT02846532. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Study of Mepolizumab Safety Syringe in Asthmatics
ClinicalTrials.gov study NCT03021304. IPD Sharing: YES. Countries: 5. Publications: 1.
Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis
ClinicalTrials.gov study NCT02931838. IPD Sharing: Not stated. Countries: 8. Publications: 4.
Efficacy and Safety of Alisporivir Alone or Combined With RBV or PEG in Chronic Hepatitis C Genotype 2 and 3 Treatment-naïve Participants
ClinicalTrials.gov study NCT01215643. IPD Sharing: Not stated. Countries: 14. Publications: 1.
A Study in Older Subject to Evaluate the Safety and Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Rivaroxaban
ClinicalTrials.gov study NCT02220725. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)
ClinicalTrials.gov study NCT01951625. IPD Sharing: Not stated. Countries: 24. Publications: 4.
Efficacy and Safety of Immunoglobulin Intravenous (Human) 10% (NewGam) in Primary Immune Thrombocytopenia
ClinicalTrials.gov study NCT01349790. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis B
ClinicalTrials.gov study NCT03038113. IPD Sharing: NO. Countries: 7. Publications: 1.
Safety and Efficacy of COVID-19 Prime-boost Vaccine in Bahrain
ClinicalTrials.gov study NCT04993560. IPD Sharing: YES. Countries: 1. Publications: 10.
Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With
ClinicalTrials.gov study NCT02616562. IPD Sharing: YES. Countries: 14. Publications: 3.
Study of Clinical Efficacy and Safety of Tosedostat in MDS
ClinicalTrials.gov study NCT02452346. IPD Sharing: NO. Countries: 1. Publications: 1.
A Safety, Tolerability and Immunogenicity Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Tetravalent Ad26.Mos4.HIV Along With Either Clade C gp140 Plus Adjuvan
ClinicalTrials.gov study NCT02935686. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects With CF, Homozygous for the F508del-CFTR Mutation
ClinicalTrials.gov study NCT02514473. IPD Sharing: Not stated. Countries: 9. Publications: 3.
Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES)
ClinicalTrials.gov study NCT03363841. IPD Sharing: UNDECIDED. Countries: 4. Publications: 2.
Study Confirming A Human Challenge Model and Investigating The Safety Of VLA1701
ClinicalTrials.gov study NCT03576183. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.